tumor immunology
DESCRIPTION
Tumor Immunology. Tumor. Cells that continue to replicate, fail to differentiate into specialized cells, and become immortal. Malignant: A tumor that grows indefinitely and spreads (metastasis)--also called cancer: kills host - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/1.jpg)
![Page 2: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/2.jpg)
Cells that continue to replicate, fail to differentiate into specialized cells, and become immortal.
1. Malignant: A tumor that grows indefinitely and spreads (metastasis)--also called cancer: kills host
2. Benign: A tumor that is not capable of metastasis: does not kill host
muscle, nerve, bone, blood
![Page 3: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/3.jpg)
Carcinoma: arising from epithelial tissue, such as glands, breast, skin, and linings of the urogenital, digestive, and respiratory systems (89.3% of all cancers)
Sarcoma: solid tumors of muscles, bone, and cartilage that arise from the embryological mesoderm (1.9% of all cancers)
Leukemia: disease of bone marrow causing excessive production of leukocytes (3.4% of all cancers)
Lymphoma, Myeloma: diseases of the lymph nodes and spleen that cause excessive production of lymphocytes (5.4% of cancers)
![Page 4: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/4.jpg)
1. Genetic factors: mutations, translocation, amplifications
2. Environmental factors: UV, chemicals, viral infections
conversion of proto-oncogenes (potential for cell transformation) to oncogenes (cell transformation)
alteration in tumor suppressor genes
![Page 5: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/5.jpg)
Control of cell growth
Growth-promotingProto-oncogenes
Growth-restrictingTumor-suppressor genes
![Page 6: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/6.jpg)
Uncontrolled cell growth
Conversion of proto-oncogenes to oncogenes: • amplification of c-erbB2 in breast cancer• point mutation of c-ras in kidney and bladder cancers• chromosome translocation of c-myc in Burkitt’s lymphoma
Altered tumor-suppressor genes:• P53 mutation in prostate cancer: failure in cell cycle arrest or apoptosis of prostate tumors• Rb mutation: fail to prevent mitosis
![Page 7: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/7.jpg)
![Page 8: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/8.jpg)
![Page 9: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/9.jpg)
Damage or mutation of DNA: Melanoma: metastatic, highly
immunogenic, Non-melanoma cancers:1. Basal cell carcinoma: rarely spreads2. Squamous cell carcinoma: can spread
![Page 10: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/10.jpg)
Free radicals and other oxidants steal electron from DNA and cause cancer: anti-oxidants (vitamins A, C)
![Page 11: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/11.jpg)
DNA viruses: papova (papilloma, SV40), hepatitis, EBV
RNA viruses: retroviruses---> Human T-lymphotropic viruses (HTLV-I and HTLV-II) cause T cell leukemia
Highly immunogenic because of viral antigens
![Page 12: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/12.jpg)
Spontaneous regression: melanoma, lymphoma
Regression of metastases after removal of primary tumor: pulmonary metastases from renal carcinoma
Infiltration of tumors by lymphocytes and macrophages: melanoma and breast cancer
Lymphocyte proliferation in draining lymph nodes
Higher incidence of cancer after immunosuppression, immunodeficiency (AIDS, neonates), aging, etc.
![Page 13: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/13.jpg)
![Page 14: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/14.jpg)
Cancer immunosurveilance: immune system can recognize and
destroy nascent transformed cells
Cancer immunoediting: immune system kill and also induce
changes in the tumor resulting in tumor escape and recurrence (epigenetic changes or Darwinian selection)
![Page 15: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/15.jpg)
![Page 16: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/16.jpg)
Antibodies recognize intact antigens while T cells recognize processed antigens associated with MHC
![Page 17: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/17.jpg)
Repertoire of T cells with low affinity against self proteins exist because of positive and negative selections in the thymus
Expression of altered self proteins by tumors will increase the affinity of T cells for tumor antigens
![Page 18: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/18.jpg)
Mutated self antigens Antigen mimicry: viral
antigens Expression of cryptic or
hidden epitopes
Expression of co-stimulatory molecules in tumors or cross presentation of tumor antigens by antigen presenting cells (APC)
![Page 19: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/19.jpg)
Cervical cancerviral transforming gene product
HPV (E7)TSA(Tumor Specific Antigen)
Melanomamelanin polymerization
gp100
Breast, ovary, GI, lung, prostate
Breast
Colorectal cancer
receptor tyrosine kinase
lubs of epithelia
cell adhesion
HER-2/neu
ERBB3
ERBB4
MUC-1
CEA
TAA(Tumor Associated Antigen)
Melanomamelanin synthesisTyrosinaseTDA(Tumor Differentiation Antigen)
Melanoma
Breast & Glioma
normal testicular protein
MAGE1
MAGE3CTA(Cancer Testis Antigen)
cancersfunctionantigen
![Page 20: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/20.jpg)
Signal I
Signal II
Effector T cells: killersEffector T cells: killers
T cells
Tumor
Cross Presentation of Tumor Antigens
![Page 21: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/21.jpg)
Non-specific: NK cells, T cells (NKG2D), macrophages, NK T cells
Antigen-specific: Antibody (ADCC, opsinization); T cells (cytokines, Fas-L, perforin/granzyme)
![Page 22: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/22.jpg)
NKTTumor
MIC
A,
B
NK T cells
IFN-Perforin/granzyme BFas-L/Fas
apoptosis
NK
G2
D
![Page 23: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/23.jpg)
sIg
Tumor
ComplementMacrophage/opsinization
FcRFabFcNK cells & ADCC
Tumor
![Page 24: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/24.jpg)
IL-2RIL-2
Anti-IL-2R Ab
T cell leukemia
![Page 25: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/25.jpg)
MH
CI
pepti
de
Apoptosis
T cell receptor (TCR)
CD8 Tumor
IFN-Granzyme B
![Page 26: Tumor Immunology](https://reader038.vdocuments.mx/reader038/viewer/2022110101/56812fbc550346895d953f28/html5/thumbnails/26.jpg)
Both genetic and environmental factors are involved in tumor formation
Immune system plays a surveillance role in controlling the development of cancer, however, it also induces epigenetic changes in tumors that result in cancer (immune editing)
Altered expression of antigens by tumors (mutation, viral antigens, cryptic epitopes), expression of co-stimulatory molecules in tumors, or cross-presentation of tumor antigens by APC results in the immune recognition of tumor cells